Trials / Completed
CompletedNCT00300924
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Diamond Headache Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test an experimental drug combination of two medications currently approved by the Food and Drug Administration (FDA) for migraine headache or other pain. These are called rizatriptan given with acetaminophen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rizatriptan co-administered with Acetaminophen |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2006-03-10
- Last updated
- 2008-05-28
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00300924. Inclusion in this directory is not an endorsement.